LOGAN KODYSZ: Open Payments
NPI 1215697941 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$543 in 22 payments from 11 companies in 2025. Trend: 2023 $390 · 2024 $468 · 2025 $543
Food & beverage: $543
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 7 | $146 |
| Tris Pharma Inc | 1 | $125 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $88 |
| Axsome Therapeutics, Inc. | 2 | $43 |
| Collegium Pharmaceutical, Inc. | 2 | $35 |
| ViiV Healthcare Company | 1 | $28 |
| Bausch Health US, LLC | 1 | $23 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| ABBVIE INC. | 1 | $15 |
| Noven Therapeutics, LLC | 1 | $14 |
Products named: REXULTI, CAPLYTA, Auvelity, Jornay PM, CABENUVA, APLENZIN, TRINTELLIX, ABILIFY ASIMTUFII.
Industry payments across AZ — which companies pay providers there.
